Neuromodulation Business Overview
Leading the Way
In the 1970s Medtronic’s research teams pioneered the development and application of neuromodulation techniques.
Neuromodulation is the targeted and regulated delivery of electrical pulses, pharmaceuticals and biologics to specific sites in the nervous system.
Today, our Neuromodulation business leads the way inimplantable neurostimulation and drug delivery systems.
These techniques help manage:
- Movement disorders (including Parkinson’s disease, Essential Tremor and dystonia)
- Chronic pain
- Overactive bladder and urinary retention
- Faecal incontinence
Deep Brain Stimulation
An innovative and proven technology that significantly improves motor function and reduces disability in patients suffering from the debilitating effects of Parkinson's disease, Essential Tremor and dystonia. These therapies use an implanted neurostimulation system to stimulate targeted nuclei in the brain to reduce symptoms associated with these movement disorders. After the implant is in place, stimulation can be non-invasively adjusted to meet each patient's needs.
Pain Management Therapies
Neurostimulation and Intrathecal Drug Delivery can be effective options for patients with chronic pain who are experiencing inadequate pain relief or uncomfortable side effects from their current pain treatments.
ITBTM Therapy eases intractable severe non-focal spasticity in patients withcerebral palsy, multiple sclerosis, traumatic brain injury, spinal cord injury and stroke by delivering an injectable liquid drug directly into the intrathecal space in small, precisely controlled doses using a pump and catheter that is surgically placed just beneath the skin in the body.
Neurostimulation for Bladder Control and for Bowel Control
This is the first implantable treatment to use electrical stimulation of the sacral nerves to manage urinary urge incontinence, urgency frequency and urinary retention. It is also used to manage faecal incontinence and constipation.
The therapy can improve the quality of life for many of the millions of people who suffer from the embarrassing and confining effects of incontinence.
Gastric Neurostimulation Therapy
Treats chronic nausea and vomiting associated with gastroparesis when conventional drug therapies are not effective. Gastroparesis is a stomach disorder in which food moves through the stomach more slowly than normal. In some patients, this condition results in severe, chronic nausea and vomiting, which cannot be adequately controlled by available drugs. These patients have difficulty eating and may require some form of tube feeding to ensure adequate nutrition.
Gastric neurostimulation therapy uses mild electrical pulses to stimulate the stomach. This electrical stimulation helps control the symptoms associated with gastroparesis including nausea and vomiting.
Adjustable Continence Therapy to Treat Stress
Urinary Incontinence in Women
Incontinence is managed with post-operatively adjustable implants placed bilaterally in a periurethral position at the bladder neck, to maintain uniform coaptation and normal bladder control.
A post-operatively adjustable treatment for stress incontinence that may be caused either by a weakening of the pelvic floor muscles or a loss of control of the sphincter muscle that controls the opening of the bladder.